Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Many COVID-19 patients experience temporary hair loss after infection, not linked to infection severity or treatment.

Patients treated in Respiratory Intensive Care Units for COVID-19 are more likely to get mood disorders than those in other care settings.

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

COVID-19 may cause temporary hair loss, which usually gets better on its own, but reducing stress and managing health issues might help recovery.

Migrant and minority communities face higher rates of alopecia due to genetic, environmental, and cultural factors, needing better healthcare access and culturally aware treatments.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

Higher testosterone and lower Vitamin D levels are linked to hair loss in female COVID-19 patients.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

COVID-19 and its vaccines can cause hair loss, which is not serious and can improve with psychological support.

SARS-CoV-2 might infect and multiply in skin tissue, possibly aiding in its transmission.

COVID-19 survivors working in healthcare may experience temporary hair loss.

Anti-IL17A therapy reduced venous leg ulcer size by 64% without major side effects.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

A woman's complete hair loss condition improved after recovering from COVID-19.

COVID-19 can increase the risk of hair loss, especially in people over 40.

A 6-year-old girl experienced temporary hair loss after mild COVID-19, which improved naturally in 8 months.

Recent research on androgenetic alopecia focuses on optimizing treatments, with promising new therapies emerging.

Most women aged 20-40 in the study lost hair diffusely and in volume over 6 weeks to 6 months, mainly due to telogen effluvium, often without a clear cause.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Skin problems like rashes and hair loss can help diagnose and predict COVID-19.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Most people with post-COVID syndrome experience symptoms like fatigue, but Omicron variants cause fewer persistent symptoms.

Nearly half of the patients had Long COVID, leading to health and work issues, especially in high-risk groups.

Computer-aided methods can speed up COVID-19 drug discovery and help find new uses for existing drugs.

Post-COVID syndrome symptoms are common and overlap with general health issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Post-COVID symptoms are common, affecting over half of the participants.

Long-COVID has diverse, long-term health impacts, especially in young people.

Women, younger age, and low BMI increase the risk of long COVID symptoms.